Cognate Insights

[null]

Media Inquiries

Cognate’s team is available to discuss our recent news further.

Contact

Charles River Laboratories Completes the Acquisition of Cognate BioServices

WILMINGTON, Mass.--(BUSINESS WIRE)--Mar. 29, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously... Read More

Charles River Laboratories to Acquire Cognate BioServices

Charles River Laboratories to Acquire Cognate BioServices – Significantly Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy Sector – –... Read More

Cognate and Nucleus Biologics announce partnership in Cell and Gene Therapies

MEMPHIS, Tennessee, January, 27 2021 /PRNewswire/ -- Cognate BioServices, Inc., the premier commercial-ready global CDMO in the Cell and Gene Therapy industry, and Nucleus... Read More

Cognate BioServices Announces Major Expansion of Manufacturing Facilities in US and Europe

Cognate BioServices, Inc., the premier commercial-ready, global CDMO in the Cell and Gene Therapy industry, announced today its plans to expand cell and gene therapy... Read More

Cognate BioServices, the Leading Biologics CDMO, Selects L7 Informatics to Implement L7|ESP for Integrated Manufacturing and Lab Operations

L7 Informatics announced that it has partnered with Cognate BioServices, Inc., the premier commercial-ready CDMO in the Cell & Gene Therapy industry, to deploy L7|ESP... Read More

BMWS20

Cognate is a proud sponsor of the 2020 Biomanufacturing World Summit.  Click the button below to schedule a meeting with the Cognate team to learn how your organization can be... Read More

Best Practices in Inter-laboratory transfer of analytical methods

Overview Working at a leading CDMO as a Director of Innovative solutions and senior scientist, I have been involved in assay development, validation, and transfer of innovative... Read More

Cognate BioServices Names Tom Pamukcoglu as VP, Global Head of Quality

MEMPHIS, Tennessee, November 2, 2020 /PRNewswire/ -- Cognate BioServices, Inc., the premier commercial-ready CDMO in the Cell & Gene Therapy industry, announced today the... Read More

WEBINAR: Best Practices for Analytical Method Transfer for Cell Therapy Products

Read More

J. Kelly Ganjei to speak at the Morgan Stanley Global Healthcare Conference

Join Cognate's CEO, J. Kelly Ganjei, as he speaks at the upcoming Morgan Stanley Global Healthcare Conference - Thursday, September 17 at 2:45pm EDT.  ... Read More
No More Posts